Our results show that AKT2 inhibition induces a unique mitochondrial-dependent DNA degradation pathway by activating nucleus translocation of AIF and EndoG during cardiac ischemia, suggesting a new function and mechanism of AKT2 in regulating cardiomyocyte survival. The gene discussed is ENDOG; the disease is myocardial ischemia.